NJ Pharmaceutical Company's Marketing Channel Optimization Strategy

The pharmaceutical circulation industry has always been an important civilian production industry,and the focus of society is an important solution to the reform of the medical and health system.In order to solve the social problems of “expensive medical treatment and difficult medical treatment” and speed up the reform of the new medical and health system,the State Council promulgated the “13th Five-Year Plan”for deepening the medical and health system reform plan for the new medical reform.Under this background,the pharmaceutical circulation industry faces huge challenge.This article compares the similarities and differences between foreign and domestic drug circulation industries and the history of development,the hospital control fees,medical insurance payment reform,medical insurance catalog adjustment,drug key monitoring,4+7 city price concentration negotiations,etc.Industry policies are the guiding direction.Starting from the literature search,using STP analysis,PEST analysis model,situation analysis method and strength factor analysis model and other analysis tools,NJ Pharmaceutical Company as a case.By analyzing its marketing data and marketing channels,and analyzing its internal and external marketing environment,it explores the overall characteristics and future development trends of the pharmaceutical distribution industry.It is pointed out that NJ Pharmaceutical Company should actively adapt to the new medical reform and policy changes such as “two-vote system” and “4+7” volume procurement,and correctly face a series of challenges such as strict supervision of the industry and new formats,new models and new technologies.Strategies to optimize marketing channels by expanding and optimizing channel breadth,adjusting and optimizing channel structure,improving and optimizing channel management,reducing and optimizing channel costs,focusing on channel research,strengthening marketing channel construction,adding brand management departments,and standardizing channel management systems And specific measures,and take safeguard measures such as building a talent team,establishing innovative mechanisms,and enhancing core competitiveness.Ensure that NJ Pharmaceutical Company can establish its main business,comply with the development of the situation,seize opportunities,and continuously improve the overall operation quality,and maintain the healthy development momentum of the company.